ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Preceptis seeks $2.5 million to develop pediatric medical device

January 5, 2012 9:55 am by | 0 Comments

A Minnesota pediatric medical device company is seeking $2.5 million, according to documents filed with the Securities & Exchange Commission.

Preceptis Medical, which is developing a solution that will allow ear, nose and throat specialists to perform ear tube surgeries safely on children right in their offices, has already raised $500,000 by issuing debt and convertible debt.

The company’s CEO – Steve Anderson – declined comment.

But in an interview last May, Anderson said that at minimum he was looking to raise $5 million and if market appetite was greater he would raise up to $10 million.

Advertisement

The target market, he said, would consist of the 1.3 million to 1.5 million ear tube surgeries that are performed in the operating room annually on children.

’What we are doing is that we are trying to come up with solutions for moving those procedures out of the OR so that the kids do not have to undergo general anesthesia,’ Anderson said at the time. ’We have come up with a way of safely delivering ear tubes right in the ENT’s office.’

At the time, Anderson also said that the device that Preceptis was developing would bring cost savings because it would transfer surgeries out of hospitals into doctor’s offices.

By transferring those surgeries out of hospitals and ambulatory surgical centers to the ENT’s office, health insurers can save 70 percent per procedure, Anderson said.

Anderson was president of Acorn Cardiovascular, which capitulated after a long battle with the Food and Drug Administration, which repeatedly denied approving the company’s heart device. After raising $100 million in venture capital, Anderson was forced to close Acorn. In late 2010, he sold its intellectual property to an undisclosed company and liquidated its assets before moving on to create Preceptis, which is developing a lower risk device than Acorn.

 


Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Know What's Next in Medical Innovation

Get the latest stories, carefully selected by our editorial team, in your inbox each morning.



Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author

0 comments

Stay Up To Date

Next Story
Navidea formally changes name from Neoprobe, gets $10M in debt financing
Close